Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · SPDR (State Street)

XBI Holdings: What State Street(R) SPDR(R) S&P(R) Biotech ETF Owns

Ticker XBI · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.35%$35/yr per $10k
5-yr return
−2.7%annualized
1-yr return
+35.8%as of Dec 2025
Net assets
$10.7Ball share classes
Holdings
161

Bottom line

What does XBI hold?

XBI held 161 positions as of Jun 30, 2026. Its largest holding is State Street Global Advisors at 5.87% of the fund, and the top 10 positions add up to 18%. By asset type it is 0% equity derivatives, 100% stocks, 6% cash & short-term funds.

Updated Aug 28, 2026

XBI top 25 holdings

#HoldingType% of fundValue
1 State Street Global Advisors
State Street Navigator Securities Lending Portfolio II
Cash & short-term funds 5.87%$630.6M
2 Apogee Therapeutics Inc Stocks 1.49%$159.8M
3 Moderna Inc Stocks 1.41%$151.6M
4 Twist Bioscience Corp Stocks 1.41%$151.1M
5 Oruka Therapeutics Inc Stocks 1.38%$148.0M
6 Kymera Therapeutics Inc Stocks 1.36%$145.9M
7 Viking Therapeutics Inc Stocks 1.30%$140.0M
8 Praxis Precision Medicines Inc Stocks 1.29%$138.5M
9 Erasca Inc Stocks 1.27%$136.4M
10 Revolution Medicines Inc Stocks 1.20%$129.3M
11 Rhythm Pharmaceuticals Inc Stocks 1.20%$129.0M
12 CG oncology Inc Stocks 1.20%$128.8M
13 SELLAS Life Sciences Group Inc Stocks 1.19%$127.7M
14 Vaxcyte Inc Stocks 1.19%$127.4M
15 Dianthus Therapeutics Inc Stocks 1.18%$127.0M
16 Cytokinetics Inc Stocks 1.18%$126.5M
17 Natera Inc Stocks 1.16%$124.8M
18 Scholar Rock Holding Corp Stocks 1.16%$124.2M
19 Roivant Sciences Ltd Stocks 1.16%$124.0M
20 Mirum Pharmaceuticals Inc Stocks 1.16%$124.0M
21 Cogent Biosciences Inc Stocks 1.14%$122.8M
22 Ultragenyx Pharmaceutical Inc Stocks 1.14%$122.4M
23 Travere Therapeutics Inc Stocks 1.13%$121.0M
24 Alkermes PLC Stocks 1.11%$119.0M
25 Krystal Biotech Inc Stocks 1.10%$118.5M

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026

Asset mix

Equity derivatives0.1%
Stocks99.9%
Cash & short-term funds5.9%

Country exposure

BM1.2%
CA0.2%
CH1.0%
IE1.2%
NL1.0%
US100.8%
VG0.5%